Mean percentage changes (95% CI) in total testosterone, SHBG and free testosterone (mITT analysis). by Chanel Avenant (409756)

Subjects:

Pairwise comparisons of hormonal results for DMPA-IM vs NET-EN expressed as mean percentage differences (95% CI) (mITT analysis). by Chanel Avenant (409756)

Subjects:

Total testosterone (nmol/L), SHBG (nmol/L) and free testosterone (pmol/L) outcomes at baseline and 25 weeks (mITT analysis). by Chanel Avenant (409756)

Subjects:

Total testosterone (nmol/L), SHBG (nmol/L) and free testosterone (nmol/L), outcomes at baseline and 25 weeks (mITT analysis). by Chanel Avenant (409756)

Subjects:

Raw data. by Adrian Bartoszek (20826922)

“…In the PTZ-induced seizure model, the application of CAF in doses over 50 mg/L resulted in a decrease in the average movement. …”

Effect of melatonin (50 μM) on the TGF-β1 (10 ng/mL, 72 h)-mediated TGF-β1/Smad pathway and EMT in HBdSMCs. by Yang Zhang (30734)

Pictorial view of some highly poisonous plants based on their LD50 values and respondent scores. by Faisal Rasool (12530732)

Titanate Nanosheets/Cellulose Composite Showing Improved Crystallinity and Decreased Water Wettability by Gamma-Irradiation by Yaowaluk Tariwong (22630109)

GTDE decreased the expression of the NLRP3 inflammasome and AGEs in the cerebral cortex. by Hui-Chuan Kuo (12368492)

In house finch Harderian glands, we identified ˜90% fewer differentially expressed genes when comparing non-infected controls to MG-infected birds from populations that are more to... by Amberleigh E. Henschen (3257235)

Empirical Bayes estimates of parameter <i>μ</i>. by Guillaume Lingas (9955528)

Subjects:

Model building procedure. by Guillaume Lingas (9955528)

Subjects:

Ratio of titers to viral load at the time of peak viral load in cynomolgus macaques infected with Lassa (top) or Ebola (bottom) virus. by Guillaume Lingas (9955528)

Subjects:

Evolution of target cells TC, productive infected cells I2, refractory cells R and immune effector F. by Guillaume Lingas (9955528)

Subjects:

BIC of models tested throughout model building. by Guillaume Lingas (9955528)

Subjects:

Mutagenesis model simulations. by Guillaume Lingas (9955528)

Subjects:

Pharmacokinetic models and concentrations predictions of treatments considered. by Guillaume Lingas (9955528)

Subjects:

Parameters distribution using model averaging (Median, 95% CI). by Guillaume Lingas (9955528)

Subjects:

Individual fits of viral load (plain lines) and viral titers (dashed line) for best model considered (<i>κ</i> = 5). by Guillaume Lingas (9955528)

Subjects:

Description of viral kinetics. by Guillaume Lingas (9955528)

Subjects: